425: Axcelis & Veeco Address Merger Lawsuits, Supplement Proxy

Axcelis Technologies and Veeco Instruments have issued supplemental disclosures to their merger proxy statement in response to stockholder lawsuits challenging the adequacy of prior disclosures.

Summary

• Axcelis Technologies, Inc. and Veeco Instruments Inc. are proceeding with their merger, initially agreed upon on September 30, 2025.
• Axcelis will hold a special meeting for stockholders on February 6, 2026, at 11:00 a.m. Eastern Time, to vote on the merger.
• Fifteen demand letters and three lawsuits have been filed by purported stockholders of Axcelis and Veeco, alleging inadequate disclosures in the preliminary and definitive proxy statements.
• The lawsuits, including "Turner v. Veeco Instruments Inc. et al.", "Clark v. Veeco Instruments Inc. et al.", and "Garfield v. Bayless et al.", claim negligence, negligent misrepresentation, failure to disclose, and breach of fiduciary duties.
• Plaintiffs seek to enjoin the merger or rescission if it is consummated, with one plaintiff filing a motion for a preliminary injunction on January 25, 2026.
• Axcelis and Veeco deny the allegations and believe the definitive proxy statement complies with applicable law, but are voluntarily providing supplemental disclosures to avoid litigation burden and potential merger delays.
• Supplemental disclosures include details on the formation of Veeco's Strategic Planning Committee, the August 12, 2025, Axcelis proposal (0.340x exchange ratio, 18% premium, 40% ownership for Veeco stockholders), and Veeco's counterproposal (0.375x exchange ratio, equal board representation, Dr. Miller as Chairperson).
• Financial analyses from J.P. Morgan (Axcelis's advisor) and UBS (Veeco's advisor) are supplemented with additional details on discounted cash flow assumptions, perpetuity growth rates (2.5% to 3.5%), discount rates (Veeco 10.0%-11.0%, Axcelis 11.0%-12.0% for J.P. Morgan; 14.0%-17.0% for UBS), and terminal multiples (12.0x to 14.0x for UBS).
• Equity research analysts' price targets for Veeco common stock ranged from $21.00 to $30.00 per share, and for Axcelis common stock from $81.00 to $90.00 per share, implying an exchange ratio reference range of 0.233x to 0.370x.
• UBS's discounted cash flow analysis indicated an implied equity value per share for Veeco common stock of $30.14 to $36.54 on a standalone basis, and $91.91 to $109.93 for Axcelis common stock on a standalone basis.
• For the combined company, including cost synergies, UBS's analysis indicated an implied equity value per share of Veeco common stock of $32.91 to $40.07, showing a potential uplift compared to standalone valuation.
• Veeco's Net Income is forecast to be $74 million in 2025E and $95 million in 2026E.
• Details on unvested equity awards for Veeco executive officers and non-employee directors, totaling significant estimated values, are provided, with non-employee director RSAs becoming fully vested upon merger.

Sentiment

Score: 4

Explanation: The filing addresses significant legal challenges to a pending merger, which introduces uncertainty and potential delays. While management denies the allegations and is taking proactive steps to mitigate litigation risk, the existence of multiple lawsuits and an injunction motion is a notable negative. The financial details provided are part of the merger valuation, not new operational results, and the combined company analysis shows a positive uplift, but this is overshadowed by the legal context.

Positives

• Axcelis and Veeco are proactively addressing stockholder concerns by voluntarily providing supplemental disclosures to avoid potential litigation burden and merger delays.
• The combined company analysis by UBS suggests a higher implied equity value per share for Veeco common stock ($32.91 to $40.07) compared to its standalone valuation ($30.14 to $36.54), indicating potential synergy benefits.
• The formation of the Veeco Strategic Planning Committee demonstrates a structured approach to evaluating strategic alternatives, even if formed as a committee of convenience.
• Key individuals like Thomas St. Dennis recused themselves from merger discussions due to dual directorships, indicating adherence to governance best practices regarding potential conflicts of interest.
• Axcelis and Veeco management maintain that the allegations in the stockholder actions are without merit and that the Definitive Proxy Statement complies with applicable law.

Negatives

• The merger faces legal challenges from stockholders, with 15 demand letters and three lawsuits filed alleging inadequate disclosures and breaches of fiduciary duties.
• One plaintiff has filed a motion for a preliminary injunction seeking to halt the stockholder vote on the merger, which could cause delays or disruption.
• The necessity of issuing supplemental disclosures, even if voluntary, indicates that the initial proxy statement was perceived as deficient by some stockholders and their legal representatives.
• The lawsuits seek significant relief, including enjoining the merger or rescission if consummated, posing a material risk to the transaction.

Risks

• Failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise.
• Failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing.
• Negative effects of the announcement of the proposed transaction.
• Risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies, and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected.
• The risk that disruptions from the proposed transaction will harm business plans and operations.
• Risks relating to unanticipated costs of integration.
• Significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities.
• Restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions.
• Potential litigation associated with the proposed transaction.
• The potential impact of the announcement or consummation of the proposed transaction on Axcelis, Veeco's or the combined company's relationships with suppliers, customers, employees, and regulators.
• Demand for the combined company's products.
• Economic, political, and social conditions in the countries in which Axcelis and Veeco, their respective customers and suppliers operate.
• Disruption to Axcelis and Veeco's respective manufacturing facilities or other operations, or the operations of Axcelis and Veeco's respective customers and suppliers, due to natural catastrophic events, health epidemics, or terrorism.
• Ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns.
• Axcelis, Veeco's, and the combined company's ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry.
• Axcelis, Veeco's, and the combined company's ability to maintain their respective technology advantage and protect their respective proprietary rights.
• Axcelis, Veeco's, and the combined company's ability to compete with new products introduced by their respective competitors.
• Axcelis, Veeco's, and the combined company's ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China.

Future Outlook

The filing primarily focuses on addressing past disclosures and current legal challenges related to the merger. Forward-looking statements are standard boilerplate regarding the risks and uncertainties of the merger, including the ability to obtain regulatory and stockholder approvals, successful integration, realization of expected benefits and synergies, and the impact of economic and industry conditions. Management expects to enter into employment arrangements with key employees across the organization, though none were negotiated prior to the merger agreement. The combined company's director compensation program is expected to be substantially similar to Axcelis's prior program.

Management Comments

• Axcelis and Veeco believe that the allegations in the Stockholder Actions are without merit.
• Axcelis denies that the Definitive Proxy Statement is deficient in any respect.
• Axcelis denies that it has violated any laws or breached any duties to Axcelis stockholders, denies all allegations in the Stockholder Actions, and believes no supplemental disclosure to the Definitive Proxy Statement was or is required under any applicable law, rule, or regulation.
• Axcelis has determined to voluntarily supplement the Definitive Proxy Statement solely to eliminate the burden and expense of potential litigation, and to avoid potential delay or disruption to the Merger.
• Axcelis believes that the disclosures set forth in the Definitive Proxy Statement comply fully with applicable law and nothing in the below supplemental disclosures will be deemed an admission of the legal necessity or materiality under applicable law of any of the disclosures set forth herein.

Industry Context

The merger involves two companies in the semiconductor capital equipment (SemiCap) industry, a sector characterized by ongoing technological advancements, significant capital spending by customers, and global economic and political influences. The industry is highly competitive, with companies like ASML Holding, Lam Research, Applied Materials, KLA Corporation, and Tokyo Electron Limited representing large-cap players, and others like ASM International, Nova, Onto Innovation, Camtek, FormFactor, and AIXTRON SE in the mid-cap segment. The ability to develop new technologies, protect proprietary rights, and navigate export control regulations (e.g., for sales to China) are critical factors for success in this dynamic environment.

Comparison to Industry Standards

• UBS's Selected Public Companies Analysis compared Veeco and Axcelis to a group of Mid-Cap SemiCap companies (ASM International NV, Nova Ltd., Onto Innovation Inc., Camtek Ltd., FormFactor, Inc., AIXTRON SE) and Large-Cap SemiCap companies (ASML Holding N.V., Lam Research Corporation, Applied Materials, Inc., KLA Corporation, Tokyo Electron Limited).
• The analysis provided EV / 2025E Adjusted EBITDA multiples ranging from 13.0x (AIXTRON SE) to 30.5x (Nova Ltd.) for Mid-Cap companies, and 16.6x (Applied Materials, Inc., Tokyo Electron Limited) to 26.7x (ASML Holding N.V.) for Large-Cap companies.
• P / 2025E Earnings multiples ranged from 20.0x (AIXTRON SE) to 36.2x (Nova Ltd.) for Mid-Cap companies, and 20.4x (Applied Materials, Inc.) to 34.1x (ASML Holding N.V.) for Large-Cap companies.
• These multiples provide a benchmark for assessing the valuation of Veeco and Axcelis within the broader semiconductor capital equipment industry, informing the financial advisors' opinions on the merger exchange ratio.

Management Changes

Corporate Governance

Legal Proceedings

• Fifteen demand letters have been received by Axcelis and Veeco from purported stockholders challenging the adequacy of certain disclosures in the Preliminary Joint Proxy Statement, Form S-4 Registration Statement, and Definitive Proxy Statement.
• Three complaints have been filed on behalf of purported stockholders: 'Turner v. Veeco Instruments Inc. et al.' (N.Y. Sup. Ct. Jan. 14, 2026), 'Clark v. Veeco Instruments Inc. et al.' (N.Y. Sup. Ct. Jan. 15, 2026), and 'Garfield v. Bayless et al.' (N.Y. Sup. Ct. Jan. 20, 2026).
• The lawsuits allege, among other things, claims for negligence, negligent misrepresentation, failure to disclose, breach of fiduciary duties, and aiding and abetting breach of fiduciary duties.
• The plaintiffs seek relief including an order enjoining the Merger or rescission if the Merger is consummated.
• On January 25, 2026, the plaintiff in the Garfield Action filed a motion for a preliminary injunction, seeking to enjoin Veeco and its directors from closing the stockholder vote on the Merger until the Definitive Proxy is supplemented.

Related Party Transactions

• Thomas St. Dennis serves as an independent director on both the Axcelis board of directors and the Veeco board of directors. He recused himself from merger discussions to manage this potential conflict.
• Dr. Russell Low, the Chief Executive Officer of Axcelis, was previously employed at Veeco as Vice President of Engineering from 2012 to 2016.

Stakeholder Impact

• **Shareholders (Axcelis & Veeco):** Face uncertainty due to ongoing litigation challenging the merger, which could delay or even prevent the transaction. However, the supplemental disclosures aim to provide more transparency and address concerns, potentially facilitating the merger vote. Veeco shareholders are expected to receive 0.340x of an Axcelis share for each Veeco share, and unvested director RSAs will fully vest.
• **Employees (Veeco & Axcelis):** The merger agreement anticipates employment arrangements with key employees across the organization, suggesting potential changes or retention efforts. Integration risks and potential disruptions are noted as general risks.
• **Directors (Veeco & Axcelis):** Veeco directors are named in lawsuits alleging breach of fiduciary duties. Non-employee directors' unvested RSAs will vest upon merger. Combined company director compensation is expected to be similar to Axcelis's prior program.
• **Customers & Suppliers:** The merger and associated disruptions or integration challenges could potentially impact relationships with customers and suppliers, as noted in the forward-looking statements.

Next Steps

• Axcelis will hold a special meeting of its stockholders on February 6, 2026, at 11:00 a.m., Eastern Time, to vote on the merger.
• Veeco and Axcelis will continue to defend against the stockholder lawsuits, which seek to enjoin or rescind the merger.
• Veeco's compensation committee may take actions in the future to mitigate the impacts of Section 280G and 4999 of the Internal Revenue Code on executive officers in connection with the Merger.

Key Dates

Recommendation

The filing details significant legal challenges to the proposed merger between Axcelis and Veeco, including multiple lawsuits and a motion for a preliminary injunction. While management is taking steps to address these issues through supplemental disclosures and denies the allegations, the existence of such litigation introduces substantial uncertainty and potential for delays or even termination of the merger. The financial analyses presented, while showing potential synergies, are contingent on the merger's successful completion. Given the legal overhang and the risk of disruption, a 'hold' recommendation is appropriate. Investors should await further clarity on the legal proceedings and the outcome of the stockholder vote before making significant investment decisions, as the stock price will likely react to developments in these areas.

Keywords

Axcelis Technologies, Veeco Instruments, Merger, SEC Filing, Proxy Statement, Stockholder Lawsuit, Semiconductor Equipment, Corporate Governance, Financial Analysis, M&A, Litigation Risk